These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7098379)

  • 21. Hepatic function in relation to acetylator phenotype in children treated with antitubercular drugs.
    Seth V; Beotra A
    Indian J Med Res; 1989 Sep; 89():306-9. PubMed ID: 2628292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.
    Sarma GR; Immanuel C; Kailasam S; Narayana AS; Venkatesan P
    Am Rev Respir Dis; 1986 Jun; 133(6):1072-5. PubMed ID: 3717759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
    Wu JC; Lee SD; Yeh PF; Chan CY; Wang YJ; Huang YS; Tsai YT; Lee PY; Ting LP; Lo KJ
    Gastroenterology; 1990 Feb; 98(2):502-4. PubMed ID: 2295408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of new and chronic tuberculous patients with ethambutol and Rifampicin (author's transl)].
    Pregowski W; Stanczuk A; Znaniecka H; Cesarz-Fronczyk M
    Z Erkr Atmungsorgane; 1976 May; 145(2):220-6. PubMed ID: 983179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population.
    Neill P; Pringle D; Mhonda M; Kusema T; Nhachi CF
    Cent Afr J Med; 1990 Apr; 36(4):104-7. PubMed ID: 2225025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver].
    Musch E; Eichelbaum M; Wang JK; von Sassen W; Ochs HR; Castro-Parra M; Dengler HJ
    Med Welt; 1982 Jun; 33(25):911-4. PubMed ID: 7109939
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
    Linna O; Uhari M
    Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
    Teixeira RL; Morato RG; Cabello PH; Muniz LM; Moreira Ada S; Kritski AL; Mello FC; Suffys PN; Miranda AB; Santos AR
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):716-24. PubMed ID: 22012226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
    Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E
    Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 32. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
    Reves R; Heilig CM; Tapy JM; Bozeman L; Kyle RP; Hamilton CD; Bock N; Narita M; Wing D; Hershfield E; Goldberg SV;
    Int J Tuberc Lung Dis; 2014 May; 18(5):571-80. PubMed ID: 24903795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)].
    Albengres E; Houin G; Breau JL; Hirsch A; Saltiel JC; Tillement JP; Chrétien J
    Nouv Presse Med; 1977 Oct; 6(32):2869-71. PubMed ID: 917803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Isoniazid induced neuropathy: consider prevention].
    Steichen O; Martinez-Almoyna L; De Broucker T
    Rev Mal Respir; 2006 Apr; 23(2 Pt 1):157-60. PubMed ID: 16788441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study].
    Fiala W; Häcki MA; Brändli O
    Schweiz Med Wochenschr; 1983 Dec; 113(51):1956-9. PubMed ID: 6658432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration.
    Farmakis M; Travlou O; Aroni S; Fertakis A
    Arzneimittelforschung; 1992 Aug; 42(8):1041-4. PubMed ID: 1418078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
    Knop P; Kindler U; Austerhoff A
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1913-5. PubMed ID: 598300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
    Dieu MJ
    J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.